# Unicycive Therapeutics, Inc. (UNCY) Unicycive Therapeutics (UNCY) sees a significant surge in mentions and positive sentiment, driven by an analyst upgrade and NDA resubmission news. The company is focused on developing treatments for orphan diseases. ### About Unicycive Therapeutics, Inc. Unicycive Therapeutics, Inc. is a biotechnology company focused on developing treatments for orphan diseases. Unicycive Therapeutics, Inc. uses the ticker $UNCY for trading. Listed in the [Stocks](/list/stocks) category. ### Insights - Unicycive Therapeutics, Inc. (UNCY) social dominance is up 275% from the previous month. - Unicycive Therapeutics, Inc. (UNCY) Galaxy Score™ is up 125% from the previous [--] months. - Unicycive Therapeutics, Inc. (UNCY) creators is up 15.65% from the previous week. ### Price: $6.20  [Price 24-Hour Time-Series Raw Data](/topic/$uncy/time-series/close.tsv) The price action is likely influenced by the positive analyst rating from Guggenheim and the news of the NDA resubmission, suggesting potential upward momentum. 24-Hour: 1.64% 7-Day: -4.62% 30-Day: 0.16% 1-Year High: $7.20 on 2026-01-27 1-Year Low: $0.532 on 2025-06-10 ### AltRank: [-----]  [AltRank 24-Hour Time-Series Raw Data](/topic/$uncy/time-series/alt_rank.tsv) Unicycive Therapeutics, Inc. (UNCY) is currently AltRank #2,271 based on combined combined social and market metrics Daily Average: [-----] [--] Week: [-----] +1,796 1-Year High: [-----] on 2026-02-14 1-Year Low: [---] on 2026-01-25 ### Galaxy Score: [-----]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$uncy/time-series/galaxy_score.tsv) Current Value: [-----] Daily Average: [--] [--] Week: [--] +5 [--] Month: [--] +18 [--] Months: [--] [---] [--] Year: [--] [---] 1-Year High: [--] on 2026-02-03 1-Year Low: [--] on 2026-01-28 ### Engagements: [---] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$uncy/time-series/interactions.tsv) Current Value: [---] Daily Average: [-----] [--] Week: [-----] -61% [--] Month: [------] +43% [--] Months: [-------] -66% [--] Year: [---------] -57% 1-Year High: [------] on 2025-06-10 1-Year Low: [--] on 2025-09-01 Engagements by network (24h): YouTube: [--] Reddit: [--] TikTok: [--] News: [--] X: [---] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$uncy/time-series/posts_active.tsv) Current Value: [--] Daily Average: [--] [--] Week: [---] -1.90% 1-Year High: [-----] on 2025-07-03 1-Year Low: [--] on 2025-09-30 Mentions by network (24h): YouTube: [--] Reddit: [--] TikTok: [--] News: [--] X: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$uncy/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning Unicycive Therapeutics, Inc. (UNCY) in the last [--] hours which is down 4.60% from [--] in the previous [--] hours Daily Average: [--] [--] Week: [---] +16% 1-Year High: [---] on 2025-07-03 1-Year Low: [--] on 2025-09-30 The most influential creators that mention Unicycive Therapeutics, Inc. in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@Wa3d251020](/creator/twitter/Wa3d251020) | [--] | [--] | [--] | [--] | | [@mariam507333959](/creator/twitter/mariam507333959) | [--] | [--] | [--] | [--] | | [@GravAnalytica](/creator/twitter/GravAnalytica) | [--] | [--] | [--] | [--] | | [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) | [--] | [-----] | [--] | [--] | | [@b2idigital](/creator/twitter/b2idigital) | [--] | [-----] | [--] | [--] | | [@SFBusinessTimes](/creator/twitter/SFBusinessTimes) | [--] | [------] | [--] | [--] | [View More](/list/creators/$uncy/100) ### Sentiment: 80%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$uncy/time-series/sentiment.tsv) Current Value: 80% Daily Average: 81% [--] Week: 80% -20% [--] Month: 82% +26% [--] Months: 82% -8% [--] Year: 82% +8% 1-Year High: 100% on 2025-03-05 1-Year Low: 12% on 2025-12-14 Most Supportive Themes: - Analyst Buy Ratings: (67%) Guggenheim reiterates a Buy rating for Unicycive with a $46 target. Most Critical Themes: ### Social Dominance: 0.00478%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$uncy/time-series/social_dominance.tsv) Current Value: 0.00478% Daily Average: 0.00705% [--] Week: 0.0045% +0.0029% [--] Month: 0.006% +0.0044% [--] Months: 0.006% -0.0019% [--] Year: 0.006% -0.0033% 1-Year High: 0.108% on 2025-07-03 1-Year Low: 0.0001% on 2025-09-30 ### Market Dominance: 0.00015040968025030504%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$uncy/time-series/market_dominance.tsv) Current Value: 0.00015040968025030504% Daily Average: 0% 1-Year High: 0.00664% on 2026-02-06 1-Year Low: 0.00015% on 2026-02-14 ### Market Cap: $132,816,827  [Market Cap 24-Hour Time-Series Raw Data](/topic/$uncy/time-series/market_cap.tsv) Current Value: $132,816,827 Daily Average: $139,537,773 [--] Week: $132,816,827 -4.90% [--] Month: $133,246,655 -1.10% 1-Year High: $154,738,051 on 2026-01-27 1-Year Low: $128,303,634 on 2026-01-30 ### Top Unicycive Therapeutics, Inc. Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "$XBI - could go either way. Down I like because its a great OPP in medium term. Up - more likely - and lean into momentum names. Lets see what happens👀. $KYTX $DNLI $UNCY $CLNN $IVVD a few of my top watch right now" [X Link](https://x.com/Biotechnerd1/status/2022365859340050495) [@Biotechnerd1](/creator/x/Biotechnerd1) 2026-02-13T17:42Z [----] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Unicycive Therapeutics (UNCY) sees a significant surge in mentions and positive sentiment, driven by an analyst upgrade and NDA resubmission news. The company is focused on developing treatments for orphan diseases.
Unicycive Therapeutics, Inc. is a biotechnology company focused on developing treatments for orphan diseases.
Unicycive Therapeutics, Inc. uses the ticker $UNCY for trading. Listed in the Stocks category.
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by the positive analyst rating from Guggenheim and the news of the NDA resubmission, suggesting potential upward momentum.
24-Hour: 1.64% 7-Day: -4.62% 30-Day: 0.16%
1-Year High: $7.20 on 2026-01-27
1-Year Low: $0.532 on 2025-06-10
AltRank 24-Hour Time-Series Raw Data
Unicycive Therapeutics, Inc. (UNCY) is currently AltRank #2,271 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] +1,796
1-Year High: [-----] on 2026-02-14
1-Year Low: [---] on 2026-01-25
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +5
[--] Month: [--] +18
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2026-02-03
1-Year Low: [--] on 2026-01-28
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [-----] -61%
[--] Month: [------] +43%
[--] Months: [-------] -66%
[--] Year: [---------] -57%
1-Year High: [------] on 2025-06-10
1-Year Low: [--] on 2025-09-01
Engagements by network (24h): YouTube: [--] Reddit: [--] TikTok: [--] News: [--] X: [---]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] -1.90%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-09-30
Mentions by network (24h): YouTube: [--] Reddit: [--] TikTok: [--] News: [--] X: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Unicycive Therapeutics, Inc. (UNCY) in the last [--] hours which is down 4.60% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +16%
1-Year High: [---] on 2025-07-03
1-Year Low: [--] on 2025-09-30
The most influential creators that mention Unicycive Therapeutics, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Wa3d251020 | [--] | [--] | [--] | [--] |
| @mariam507333959 | [--] | [--] | [--] | [--] |
| @GravAnalytica | [--] | [--] | [--] | [--] |
| @AponiaAnalytics | [--] | [-----] | [--] | [--] |
| @b2idigital | [--] | [-----] | [--] | [--] |
| @SFBusinessTimes | [--] | [------] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 80%
Daily Average: 81%
[--] Week: 80% -20%
[--] Month: 82% +26%
[--] Months: 82% -8%
[--] Year: 82% +8%
1-Year High: 100% on 2025-03-05
1-Year Low: 12% on 2025-12-14
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00478%
Daily Average: 0.00705%
[--] Week: 0.0045% +0.0029%
[--] Month: 0.006% +0.0044%
[--] Months: 0.006% -0.0019%
[--] Year: 0.006% -0.0033%
1-Year High: 0.108% on 2025-07-03
1-Year Low: 0.0001% on 2025-09-30
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00015040968025030504%
Daily Average: 0%
1-Year High: 0.00664% on 2026-02-06
1-Year Low: 0.00015% on 2026-02-14
Market Cap 24-Hour Time-Series Raw Data
Current Value: $132,816,827
Daily Average: $139,537,773
[--] Week: $132,816,827 -4.90%
[--] Month: $133,246,655 -1.10%
1-Year High: $154,738,051 on 2026-01-27
1-Year Low: $128,303,634 on 2026-01-30
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$XBI - could go either way. Down I like because its a great OPP in medium term. Up - more likely - and lean into momentum names. Lets see what happensđź‘€. $KYTX $DNLI $UNCY $CLNN $IVVD a few of my top watch right now"
X Link @Biotechnerd1 2026-02-13T17:42Z [----] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$uncy